Vontobel Holding’s Pfizer PFE Stock Holding History

Vontobel Holding’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,000	Closed	-$1.25M	–	1419
2025 Q4	$1.25M	Buy	+50,000	New	+$1.26M	﹤0.01%	698

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vontobel Holding's PFE Position: Q2 2026 in Review

Vontobel Holding increased its Pfizer (PFE) stake by 30% in Q2 2026, buying an estimated $5.48M and bringing the position to 916,169 shares worth $22.1M. The position accounts for 0.07% of the portfolio, ranked #222.

Vontobel Holding first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $45.1M in Q1 2021. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Vontobel Holding held 916,169 shares of Pfizer worth $22.1M as of Q2 2026.
Vontobel Holding bought 209,524 Pfizer shares in Q2 2026, an estimated $5.48M.
Pfizer made up 0.07% of Vontobel Holding's portfolio in Q2 2026, its #222 holding.
Vontobel Holding first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
Vontobel Holding's Pfizer position peaked at $45.1M in Q1 2021.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.